Betulin modulates the EGFR/JAK2/STAT3 pathway to alleviate cognitive impairment and microglia-mediated neuroinflammation in stroke mice
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.116441 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Zheyu Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, the Second Affiliated Hospital of Wenzhou Medical University, 325027 Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Microglia, Triterpenes, Neuroinflammatory Diseases, Cognitive Dysfunction. Die Arbeit nennt 43 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Post-stroke cognitive impairment (PSCI) is characterized by progressive cognitive decline following ischemic stroke, and recent studies have suggested that natural compounds may offer therapeutic benefits; however, the effects and mechanisms of Betulin in PSCI remain unclear. Male C57BL/6 mice were subjected to ischemic stroke surgery to induce PSCI and treated with Betulin (50 mg/kg/day) for 3 weeks, followed by assessments of cognitive impairment, pathological changes, and the production of pro-inflammatory cytokines. Network pharmacology and RNA sequencing were performed to explore potential mechanisms. In vitro, BV2 microglia were stimulated with lipopolysaccharide to examine the anti-inflammatory effects of Betulin. Betulin improved cognitive performance, reduced microglial activation, and attenuated neuroinflammation, as evidenced by decreased levels of TNF-α, IL-1β, and IL-6. Mechanistically, the epidermal growth factor receptor (EGFR)/JAK2/STAT3 pathway was identified as a key pathway potentially involved in these effects. Further experiments with EGFR point-mutation constructs indicated that disrupting the Betulin-EGFR interaction attenuated the inhibitory effect of Betulin on the EGFR/JAK2/STAT3 pathway. Collectively, these findings suggest that Betulin mitigates microglia-driven neuroinflammation by targeting EGFR and may represent a potential therapeutic candidate for PSCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, the Second Affiliated Hospital of Wenzhou Medical University, 325027 Wenzhou, Zhejiang, China.
- School of Public Health, Wenzhou Medical University, 325027 Wenzhou, Zhejiang, China.
- School of Public Health, Wenzhou Medical University, 325027 Wenzhou, Zhejiang, China. Electronic address: wzjiaming_liu@163.com.
- Department of Neurology, the Second Affiliated Hospital of Wenzhou Medical University, 325027 Wenzhou, Zhejiang, China. Electronic address: sunjwz@126.com.
Zitieren
APA
Fang, Z., Xiang, K., Lv, X., Li, Q., Dai, C., Yang, Y., Lin, Y., Liu, J., & Sun, J. (2026). Betulin modulates the EGFR/JAK2/STAT3 pathway to alleviate cognitive impairment and microglia-mediated neuroinflammation in stroke mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116441
Vancouver
Fang Z, Xiang K, Lv X, Li Q, Dai C, Yang Y, et al. Betulin modulates the EGFR/JAK2/STAT3 pathway to alleviate cognitive impairment and microglia-mediated neuroinflammation in stroke mice. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116441
BibTeX
@article{Fang2026,
author = {Fang, Zheyu and Xiang, Kun and Lv, Xinhuang and Li, Qiyao and Dai, Conghui and Yang, Yao and Lin, Yan and Liu, Jiaming and Sun, Jing},
title = {Betulin modulates the EGFR/JAK2/STAT3 pathway to alleviate cognitive impairment and microglia-mediated neuroinflammation in stroke mice},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.116441}
}
EUVIMED